Formosa Laboratories Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Chen-Yu Cheng
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | 9.0% |
| Management average tenure | less than a year |
| Board average tenure | 11.6yrs |
Recent management updates
Recent updates
Risks To Shareholder Returns Are Elevated At These Prices For Formosa Laboratories, Inc. (TWSE:4746)
Sep 20
Investors Can Find Comfort In Formosa Laboratories' (TWSE:4746) Earnings Quality
May 22Benign Growth For Formosa Laboratories, Inc. (TWSE:4746) Underpins Its Share Price
Apr 19Here's Why Formosa Laboratories (TPE:4746) Has A Meaningful Debt Burden
Apr 19Does Formosa Laboratories, Inc.'s (TPE:4746) Weak Fundamentals Mean A Downturn In Its Stock Should Be Expected?
Mar 16What Type Of Returns Would Formosa Laboratories'(TPE:4746) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?
Feb 08Formosa Laboratories (TPE:4746) Is Making Moderate Use Of Debt
Jan 11
Formosa Laboratories's (TPE:4746) Earnings Are Growing But Is There More To The Story?
Dec 13CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | NT$393m |
| Jun 30 2024 | n/a | n/a | NT$256m |
| Mar 31 2024 | n/a | n/a | NT$55m |
| Dec 31 2023 | n/a | n/a | NT$126m |
| Sep 30 2023 | n/a | n/a | NT$270m |
| Jun 30 2023 | n/a | n/a | NT$876m |
| Mar 31 2023 | n/a | n/a | NT$785m |
| Dec 31 2022 | NT$8m | NT$6m | NT$409m |
Compensation vs Market: Insufficient data to establish whether Chen-Yu's total compensation is reasonable compared to companies of similar size in the TW market.
Compensation vs Earnings: Insufficient data to compare Chen-Yu's compensation with company performance.
CEO
Chen-Yu Cheng
no data
Tenure
NT$7,943,000
Compensation
Dr. Chen-Yu Cheng, Ph D., founded Formosa Laboratories, Inc. in 1996 and serves as its Chairman of the Board of Directors and serves as its President at Formosa Laboratories, Inc. since 2021. Dr. Cheng ser...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President & Chairman of the Board | no data | NT$7.94m | 8.99% NT$ 784.9m | |
| Senior Vice President of Business | less than a year | no data | 0.19% NT$ 16.7m | |
| Senior Vice President of Corporate Support Division | less than a year | no data | 0.014% NT$ 1.2m | |
| Senior Vice President of Quality & Regulatory Compliance Division | less than a year | no data | no data | |
| Senior Vice President of Production | less than a year | no data | 0.024% NT$ 2.1m | |
| Vice President | no data | no data | 0.0090% NT$ 784.0k | |
| Vice President | no data | no data | 0.019% NT$ 1.6m | |
| Chief Information Security Officer | 1.4yrs | no data | no data |
1.0yrs
Average Tenure
Experienced Management: 4746's management team is not considered experienced ( 1 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President & Chairman of the Board | no data | NT$7.94m | 8.99% NT$ 784.9m | |
| Director | 11.6yrs | no data | no data | |
| Independent Director | 11.6yrs | no data | no data | |
| Director | 11.6yrs | no data | no data | |
| Director | 11.6yrs | NT$520.00k | 0.44% NT$ 38.5m | |
| Director | 11.6yrs | no data | no data | |
| Director | 11.6yrs | NT$1.11m | 0.044% NT$ 3.9m | |
| Member of the Supervisory Board | 11.6yrs | no data | no data | |
| Independent Director | 2.6yrs | NT$410.00k | no data | |
| Independent Director | 1.6yrs | NT$340.00k | no data | |
| Independent Director | 1.6yrs | NT$328.00k | no data | |
| Independent Director | 2.6yrs | NT$410.00k | no data |
11.6yrs
Average Tenure
Experienced Board: 4746's board of directors are seasoned and experienced ( 11.6 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/10 00:31 |
| End of Day Share Price | 2025/01/10 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Formosa Laboratories, Inc. is covered by 7 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Pinghan Hsieh | Capital Securities Corporation |
| Zhennan Lee | Jih Sun Securities Investment Consulting Co., Ltd. |
| null null | KGI Securities Co. Ltd. |